Bio/Pharma Business

August 22, 2022

ProBioGen will collobarate with NextPoint Therapeutics to develop and manufacture its lead antibody candidate.

August 12, 2022

Merck, known as MSD outside of the United States and Canada, will collaborate with Cerevance to identify novel targets for Alzheimer’s disease.

August 11, 2022

Guest contributor B.S. Sathya Durga discusses the importance of modernizing India's pharmaceutical manufacturing industry.

August 10, 2022

Pfizer’s $5.4 billion acquisition of Global Blood Therapeutics is expected to strengthen its sickle cell disease portfolio.

August 10, 2022

Sartorius’ £415 million (US$429 million) acquisition of Albumedix is intended to bolster its portfolio with recombinant albumin-based solutions.

August 10, 2022

Sanofi and Innovent have entered into a strategic collaboration to accelerate development of oncology medicines and expand their presence in China.

August 10, 2022

Democrats approve curbs for Medicare plans, but not for commercial drug coverage.

August 09, 2022

Amgen’s acquisition of Chemocentryx includes the autoimmune disease drug Tavneos (avacopan).

August 05, 2022

La Jolla’s acquisition of Carterra’s LSA Platform is designed to advance their immunological and infectious disease research.

August 03, 2022

Ipsen and Marengo Therapeutics will collaborate to advance two precision immuno-oncology candidates.